Total Assets
GOOG Return Rate$Novo Nordisk AS(NVO.US) The fundamentals haven't changed, but the move to lower expectations and detonate the bomb early is really incomprehensible. Anyway, the expected risks won't materialize in the near term, and the sales of oral medications will lead to a major reversal in the Q1 report. Let's wait and see.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments